| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -555K | 100% | $43.67 | -$24.2M |
| Net | -8 | -555K | -100% | -$24.2M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Thilo Schroeder | Director | $170M | Nov 9, 2023 | ||
| Third Rock Ventures III, L.P. | 10%+ Owner | $138M | Jun 8, 2022 | ||
| Alexis Borisy | Director | $89.9M | Jun 20, 2024 | ||
| Stephen Michael Kelsey | President, Research and Development | $15.7M | -$6.57M | -29.5% | Nov 13, 2024 |
| Margaret Horn | Chief Operating Officer | $6.66M | -$4.11M | -38.1% | Oct 11, 2024 |
| Jack Anders | Chief Financial Officer | $4.98M | -$1.16M | -18.9% | Oct 11, 2024 |
| Sandra Horning | Director | $3.59M | Jun 20, 2024 | ||
| Lorence H. Kim | Director | $2.69M | Jun 20, 2024 | ||
| Wei Lin | Chief Medical Officer | $2.65M | -$209K | -7.31% | Jun 17, 2024 |
| Jeff Cislini | General Counsel | $2.38M | -$1.32M | -35.8% | Nov 15, 2024 |
| Xiaolin Wang | Officer | $2.28M | Mar 1, 2024 | ||
| Elizabeth M. Anderson | Director | $1.81M | Jun 20, 2024 | ||
| Neil Exter | Director | $1.32M | Jun 16, 2022 | ||
| Mark A. Goldsmith | President and Chief Executive Officer, Director | $1.29M | -$10.2M | -88.7% | Nov 1, 2024 |
| Sushil Patel | Director | $1.08M | -$445K | -29.2% | Oct 31, 2024 |
| Flavia Borellini | Director | $842K | Jun 20, 2024 | ||
| Vincent A. Miller | Director | $641K | Jun 22, 2021 | ||
| Barbara Weber | Director | $627K | -$250K | -28.5% | Oct 8, 2024 |
| Eric Schmidt | Director | $574K | Jun 8, 2023 | ||
| Third Rock Ventures II, L.P. | 10%+ Owner | $349K | Jun 3, 2021 | ||
| Frank Clyburn | Director | $322K | Aug 5, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|